BioNTech SE (BNTX) Share-based Compensation (2019 - 2025)
BioNTech SE's Share-based Compensation history spans 7 years, with the latest figure at $28.1 million for Q4 2025.
- On a quarterly basis, Share-based Compensation rose 11.71% to $28.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $120.3 million, a 9.83% increase, with the full-year FY2025 number at $120.0 million, up 11.28% from a year prior.
- Share-based Compensation hit $28.1 million in Q4 2025 for BioNTech SE, down from $32.6 million in the prior quarter.
- Over the last five years, Share-based Compensation for BNTX hit a ceiling of $73.6 million in Q3 2021 and a floor of $20.87 in Q1 2021.
- Historically, Share-based Compensation has averaged $26.1 million across 5 years, with a median of $22.9 million in 2022.
- The widest YoY moves for Share-based Compensation: up 269441191.15% in 2021, down 100.0% in 2021.
- Tracing BNTX's Share-based Compensation over 5 years: stood at $23.5 million in 2021, then decreased by 3.42% to $22.6 million in 2022, then crashed by 32.54% to $15.3 million in 2023, then soared by 64.36% to $25.1 million in 2024, then rose by 11.71% to $28.1 million in 2025.
- Business Quant data shows Share-based Compensation for BNTX at $28.1 million in Q4 2025, $32.6 million in Q3 2025, and $36.3 million in Q2 2025.